• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Icongene therapy

gene therapy

As part of its quest to “discover the science of humanity,” the Truveta Genome Project will gather the de-identified genetic data of tens of millions of consented volunteers, health data startup Truveta announced Jan. 13, 2025.
Health
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By Lindsey LeakeJanuary 16, 2025
Rylae-Ann Poulin
Health
‘There’s a lot of exciting times ahead of us’: Game-changing gene therapy for brain disorders is right around the corner
By Laura Ungar and The Associated PressJanuary 24, 2023
Novartis Zolgensma Gene Therapy Sales
Newsletters
Why a drug that costs $2.1 million per dose is on a sales streak
By Sy MukherjeeJanuary 29, 2020
Landlord To The Biotechs
Health
Biogen Acquires Nightstar Therapeutics in $800 Million Gene Therapy Deal
By Don ReisingerMarch 4, 2019
Pipette adding sample to petri dish with DNA profiles in background
Health
Roche Bids $4.8 Billion for U.S.-Based Gene Therapy Specialist Spark
By Tim Loh, Naomi Kresge and BloombergFebruary 25, 2019
Novartis CEO Has One New Breakthrough Drug in the Medicine Cabinet: But It Could Be Costly
Leadership
Novartis CEO Has One New Breakthrough Drug in the Medicine Cabinet: But It Could Be Costly
By Susie GharibNovember 30, 2018
Why Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard Of
Health
Why Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard Of
By Hallie DetrickApril 9, 2018
Antisense and Sensibility: Why RNA Is the New DNA
Health
Antisense and Sensibility: Why RNA Is the New DNA
By Clifton LeafJanuary 4, 2018
Iris Network Student
Health
The First FDA-Approved Gene Therapy Can Cure a Type of Blindness—But May Cost $1 Million
By Sy MukherjeeDecember 19, 2017
Iris Network Student
Health
Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?
By Sy MukherjeeNovember 16, 2017
Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
Health
Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
By Sy MukherjeeAugust 31, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
Commentary
Innovative Drugs Deserve Innovative Pricing
By David Agus, Dana Goldman and Bethany CiancioloAugust 31, 2017
Sickle Cell Anemia SEM
Health
Bluebird Bio’s New Treatment Cured Sickle Cell in a Teenage Boy
By Sy MukherjeeMarch 3, 2017
DNA genetic testing (crop)
Health
GlaxoSmithKline Is One Step Closer to EU Approval for Its Gene Therapy
By Sy MukherjeeApril 4, 2016
1
  • 1
1
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.